Headaches on Mounjaro: Why They Happen and How to Manage Them

Headaches are one of the most commonly reported side effects during the early weeks of Mounjaro (tirzepatide) treatment. Clinical trials, including the SURMOUNT-1 and SURMOUNT-2 studies published in the New England Journal of Medicine, recorded headaches in approximately 4 to 6 per cent of participants taking tirzepatide. While usually mild and temporary, understanding why they occur and knowing what you can do about them makes a real difference to your comfort during treatment.

In this guide, the CutKilo medical team explains the main causes of headaches on Mounjaro, when they are most likely to occur, and practical strategies for managing them at home. We also cover the warning signs that should prompt you to seek medical advice.

Mounjaro-related headaches are typically caused by changes in blood sugar regulation, reduced food and fluid intake, or the body’s adjustment to a new medication. They tend to appear in the first two to four weeks of treatment or shortly after a dose increase and usually resolve on their own. Staying hydrated, eating regular small meals, and working with your doctor to manage dose titration carefully can all help. In the vast majority of cases, headaches are not a reason to stop treatment.

Several factors contribute to headaches during Mounjaro treatment. Understanding the underlying mechanisms can help you take targeted steps to prevent or reduce them.

Blood sugar fluctuations. Tirzepatide acts on both GIP and GLP-1 receptors, improving insulin sensitivity and lowering blood glucose. As your body adjusts to these metabolic changes, temporary fluctuations in blood sugar levels can trigger headaches. This is especially common in the first few weeks of treatment when your glycaemic response is still calibrating.

Dehydration. Mounjaro reduces appetite significantly in most patients. When you eat less, you also tend to drink less, and many people do not compensate adequately for this reduction. Decreased fluid intake leads to dehydration, which is one of the most common causes of headaches both generally and during GLP-1 receptor agonist treatment specifically.

Reduced calorie intake. Eating substantially fewer calories than your body is accustomed to can trigger tension headaches. This is particularly common if meals are being skipped entirely rather than simply reduced in portion size. Furthermore, rapid shifts in eating patterns may compound the effect during the early weeks of treatment.

Nausea-related tension. If you are experiencing nausea alongside your headaches, the physical stress of feeling unwell can itself contribute to tension-type headaches. According to the MHRA Summary of Product Characteristics for tirzepatide, nausea is reported in approximately 12 to 18 per cent of patients during clinical trials.

Caffeine withdrawal. Many patients find they consume less tea, coffee, or caffeinated drinks once their appetite decreases on Mounjaro. If you were a regular caffeine consumer, this sudden reduction can trigger withdrawal headaches that persist for several days. For a detailed look at how caffeine interacts with Mounjaro treatment, see our guide to caffeine, coffee, and energy drinks on Mounjaro.

Most patients who experience headaches on Mounjaro report them during two specific windows. The first is within the initial two to four weeks of starting treatment at the 2.5 mg introductory dose. The second common window is shortly after a dose increase, particularly when moving from 5 mg to 7.5 mg or from 7.5 mg to 10 mg.

In the SURMOUNT-1 trial, headache frequency was highest during the titration phase and decreased as participants stabilised on their maintenance dose. For most people, headaches resolve within one to two weeks of each adjustment as the body adapts to the new level of medication.

It is also worth noting that patients who experience headaches at the starting dose do not necessarily experience them again with subsequent dose increases. Conversely, some patients report headaches only at higher doses. Individual variation is considerable, and your prescribing doctor can help you navigate the titration schedule based on your specific response.

Stay hydrated. Aim for at least two litres of water daily, and more if you are physically active or the weather is warm. Keeping a water bottle with you throughout the day can help establish this habit. Many patients find that increasing their fluid intake alone resolves their headaches entirely.

Eat regular small meals. Rather than skipping meals because you do not feel hungry, eat small, nutrient-dense meals at consistent intervals. This helps stabilise blood sugar levels and provides a baseline of nutrition that supports your overall wellbeing. In particular, including protein and complex carbohydrates at each meal can help maintain steady glucose levels.

Monitor caffeine intake. If you suspect caffeine withdrawal, try reducing your intake gradually rather than stopping abruptly. Cutting from four cups of coffee to one over the course of a week is far more comfortable than eliminating caffeine overnight.

Over-the-counter pain relief. Paracetamol is generally safe to take alongside Mounjaro for occasional headache relief. Ibuprofen may also be used short-term unless you have been advised otherwise by your doctor. However, if you find yourself relying on painkillers for headaches more than two to three times per week, speak with your prescribing clinician.

Manage your dose titration carefully. CutKilo’s doctor-led approach includes careful dose titration based on your individual response. If headaches are persistent or severe after a dose increase, your doctor may recommend staying at the current dose for an additional four weeks before increasing further. For patients who experience ongoing fatigue alongside their headaches, a slower titration schedule often helps both symptoms simultaneously.

Keep a symptom diary. Recording when your headaches occur, their severity, and what you ate or drank that day can help your doctor identify patterns. This information is particularly valuable during dose adjustments and makes follow-up consultations more productive.

In rare cases, headaches during GLP-1 receptor agonist treatment may indicate a more significant issue. According to the MHRA Summary of Product Characteristics for tirzepatide, headaches are listed as a common side effect (affecting 1 in 10 to 1 in 100 patients) and are not typically a cause for concern.

However, you should seek medical attention promptly if your headaches are unusually severe or sudden in onset, accompanied by visual disturbances or confusion, associated with a stiff neck and sensitivity to light, or not responding to standard pain relief after several days of consistent use.

These symptoms could indicate dehydration requiring medical intervention, significant hypoglycaemia (particularly if you are also taking a sulphonylurea or insulin), or, very rarely, an unrelated neurological condition that coincided with starting treatment. Your CutKilo doctor can help you determine whether your symptoms require further investigation.

Tension headaches are by far the most common type associated with Mounjaro. These present as a dull, pressing sensation across the forehead or around the back of the head and neck. They tend to worsen later in the day, particularly if you have not eaten or drunk enough.

Migraine-type headaches are less commonly reported in clinical trial data but can occur, particularly in patients with a pre-existing history of migraines. If you experience throbbing, one-sided headaches with nausea or light sensitivity, it is worth discussing migraine-specific management with your doctor. Additionally, keeping a record of migraine triggers during treatment can help your medical team tailor your care.

Cluster headaches and other rare headache subtypes have not been specifically linked to tirzepatide in the published trial literature. If you develop a headache pattern that is significantly different from what you have experienced before, this should be discussed with your prescribing clinician regardless of its severity.

How long do headaches last on Mounjaro? Most headaches resolve within one to two weeks of starting treatment or adjusting your dose. If they persist beyond three to four weeks at a stable dose, speak with your prescribing doctor about adjusting your treatment plan.

Can I take paracetamol with Mounjaro? Yes. Paracetamol does not interact with tirzepatide and is considered safe for occasional use to manage headaches. Follow standard dosing guidance and avoid exceeding four grams in 24 hours.

Should I stop Mounjaro if I get headaches? In the vast majority of cases, no. Headaches are a recognised and usually temporary side effect. Stopping treatment for mild headaches would mean losing the significant metabolic benefits that Mounjaro provides. If your headaches are severe or persistent, your doctor may adjust your dose rather than discontinue treatment entirely.

Are headaches worse at higher doses? Some patients report headaches after each dose increase, but this is not universal. The SURMOUNT trials showed that side effects, including headaches, tended to diminish over time regardless of the maintenance dose reached. Gradual titration, which is standard in CutKilo’s protocol, helps minimise this effect.

Do headaches on Mounjaro mean my blood sugar is too low? Not necessarily. While hypoglycaemia can cause headaches, it is uncommon in patients taking Mounjaro alone without insulin or a sulphonylurea. Other causes such as dehydration and reduced food intake are far more likely explanations.

Is drinking more water really enough to help? For many patients, yes. Dehydration is the single most common reversible cause of headaches on Mounjaro. Increasing daily water intake to two to two and a half litres resolves the issue for a significant proportion of patients without any further intervention.

Headaches on Mounjaro are common, usually mild, and almost always temporary. They are most likely to occur during the first few weeks of treatment or after a dose increase, and are primarily driven by changes in hydration, blood sugar regulation, and eating patterns. Staying well hydrated, eating small regular meals, and working with your doctor to manage dose titration are the most effective strategies for relief.

If headaches persist beyond the expected adjustment period or are accompanied by more concerning symptoms, speak with your prescribing clinician promptly. CutKilo’s supervised, doctor-led model means your treatment is monitored at every stage, so support is always available when you need it.